KT
Kevin Tang bought $12.5M of AUPH stock
Kevin Tang, Chief Executive Officer, 10% of Aurinia Pharmaceuticals Inc. (AUPH), bought 814,606 shares of AUPH stock worth $12.5M, per an SEC Form 4 filed Jun 2, 2026.
It was an open-market purchase.
The trade happened on May 29, 2026, 4 days before it was made public.
AUPH has moved +5.7% since the trade date, from $15.33 to $16.21 (Nov 5, 2026 close).
- Traded
- May 29, 2026
- Disclosed
- Jun 2, 2026
- Filing delay
- 4 days
- Price since
- +5.7%
- Role
- Chief Executive Officer, 10%
- Source
- SEC Form 4